Robert Barrow - Jan 1, 2022 Form 3 Insider Report for Mind Medicine (MindMed) Inc. (MNMD)

Role
Chief Executive Officer, Director
Signature
/s/ Robert Barrow
Stock symbol
MNMD
Transactions as of
Jan 1, 2022
Transactions value $
$0
Form type
3
Date filed
1/10/2022, 08:26 PM
Previous filing
Mar 28, 2022
Next filing
Jan 19, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding MNMD Subordinate Voting Shares 2.44M Jan 1, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding MNMD Stock Option (Right to Buy) Jan 1, 2022 Subordinate Voting Shares 1M $3.09 Direct F2, F3
holding MNMD Stock Option (Right to Buy) Jan 1, 2022 Subordinate Voting Shares 2.52M $2.42 Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one subordinate voting share of the Issuer. Of these RSUs, (i) 1,935,000 shall vest as to 25% on January 15, 2022 and the remainder shall vest in 36 equal monthly installments beginning on January 15, 2023; and (ii) 500,000 vest in 4 equal annual installments beginning on January 15, 2022, subject, to the Reporting Person providing continuous service to the Issuer on each such foregoing date.
F2 25% of the shares underlying the option shall vest and become exercisable on January 15, 2022; the remaining shares underlying the option shall vest and become exercisable in 30 equal monthly installments beginning on February 15, 2022, subject to the Reporting Person providing continuous service to the Issuer on each such date.
F3 The option grant has an exercise price of $3.93 Canadian Dollars. This represents the exercise price in United States Dollars.
F4 25% of the shares underlying the option shall vest and become exercisable on January 15, 2022; the remaining shares underlying the option shall vest and become exercisable in 36 equal monthly installments beginning on January 15, 2023, subject to the Reporting Person providing continuous service to the Issuer on each such date.
F5 The option grant has an exercise price of $3.08 Canadian Dollars. This represents the exercise price in United States Dollars.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney